Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic option for infections with ...
Oct 24, 2022
1
217
Ulcerative colitis is the most common type of inflammatory bowel disease, characterized by chronic ulcers and inflammation in the colon and rectum. Symptoms can be lifelong and range from mild to life-threatening. There is ...
Oct 18, 2022
0
53
The process of metastasis is when cancer cells gain motility and spread to other sites of the body. Because this is one of the main causes of cancer-related deaths, researchers have aimed to develop therapeutic strategies ...
Oct 18, 2022
0
48
A study led by an Oregon State University pharmaceutical sciences researcher has produced a proof of principle for a new "universal" means of treating COVID-19.
Oct 18, 2022
0
38
Acute kidney injury (AKI) is a frequent complication associated with various diseases and particularly affects patients on intensive care units. However, the mechanisms underlying AKI are incompletely understood. Just recently, ...
Oct 5, 2022
0
42
A research group led by CiRA Junior Associate Professor Kazuo Takayama and Associate Professor Yoshiaki Okada of Osaka University has revealed that SARS-CoV-2 disrupts the vascular endothelial barrier by suppressing the expression ...
Sep 28, 2022
0
71
Premature babies in neonatal units could be given personalized prescriptions of bacteria directly into their stomachs to improve health and reduce disease risk, new research has revealed.
Sep 27, 2022
0
83
Vanderbilt researchers have identified a protein that is key to the "education" of immature T cells in the thymus. The findings, reported in the Journal of Experimental Medicine, could inform therapeutic strategies for enhancing ...
Sep 2, 2022
0
4
King's researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.
Aug 31, 2022
0
51
In the normal small intestine, the levels of SFB and Th17 cells are both maintained as they counterbalance each other. Th17 cells release IL-17 to limit unwanted expansion of SFB, whereas a decrease in the number of SFB eases ...
Aug 26, 2022
0
53
